Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
84.78 USD | -1.37% | +0.58% | +27.38% |
Financials (USD)
Sales 2024 * | 5.31B | Sales 2025 * | 5.78B | Capitalization | 8.66B |
---|---|---|---|---|---|
Net income 2024 * | 414M | Net income 2025 * | 464M | EV / Sales 2024 * | 2.09 x |
Net Debt 2024 * | 2.42B | Net Debt 2025 * | 2.14B | EV / Sales 2025 * | 1.87 x |
P/E ratio 2024 * |
21.3
x | P/E ratio 2025 * |
19.1
x | Employees | 27,209 |
Yield 2024 * |
0.7% | Yield 2025 * |
0.7% | Free-Float | 85.65% |
Latest transcript on Encompass Health Corporation
1 day | +1.31% | ||
1 week | +2.84% | ||
Current month | -0.50% | ||
1 month | -0.66% | ||
3 months | +12.44% | ||
6 months | +32.65% | ||
Current year | +28.84% |
Managers | Title | Age | Since |
---|---|---|---|
Mark Tarr
CEO | Chief Executive Officer | 62 | 92-12-31 |
Douglas Coltharp
DFI | Director of Finance/CFO | 62 | 10-05-05 |
Chief Tech/Sci/R&D Officer | 64 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Leslye Katz
BRD | Director/Board Member | 69 | 13-01-24 |
Chairman | 62 | 19-12-31 | |
Director/Board Member | 68 | 21-09-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.44% | 7 M€ | +5.53% | ||
1.39% | 2 M€ | +9.08% | ||
1.09% | 231 M€ | -1.00% | ||
1.09% | 1 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-11 | 84.98 | -1.14% | 52 405 |
24-06-10 | 85.96 | +1.31% | 610,857 |
24-06-07 | 84.85 | -0.49% | 249,035 |
24-06-06 | 85.27 | -0.86% | 494,263 |
24-06-05 | 86.01 | +1.79% | 567,690 |
Delayed Quote Nyse, June 10, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+28.84% | 8.66B | |
-25.47% | 15.12B | |
-3.60% | 11.57B | |
+7.54% | 10.43B | |
-7.47% | 7.45B | |
+6.42% | 6.74B | |
+8.59% | 6.48B | |
-2.79% | 4.35B | |
+11.89% | 4.17B | |
+26.42% | 3.9B |
- Stock Market
- Equities
- EHC Stock